General Surgery and Homeopathic Therapeutics Winter 2022 Solved Paper [Q.2 SAQ;s]

2. Short answer Questions.

a] Cervical Rib - Etiology, Clinical Findings differential Diagnosis 

       

Cervical Rib

Etiology

A cervical rib is a supernumerary or extra rib arising from the seventh cervical vertebra (C7). It is a congenital anomaly, meaning it is present at birth, resulting from genetic and developmental factors that influence the segmentation and differentiation of the vertebrae during embryogenesis. The exact cause is not well understood, but it is thought to involve both genetic predispositions and environmental influences during fetal development.

 Clinical Findings

1. Asymptomatic: Many individuals with a cervical rib are asymptomatic and the condition is discovered incidentally during imaging for other reasons.

2. Thoracic Outlet Syndrome (TOS): Symptoms can arise when the cervical rib causes compression of neurovascular structures, leading to thoracic outlet syndrome.

 Symptoms include:

   - Neurological Symptoms: Numbness, tingling, pain, or weakness in the arm and hand, often due to brachial plexus compression.

   - Vascular Symptoms: Swelling, discoloration, or pain in the arm due to subclavian artery or vein compression.

3. Palpable Mass: In some cases, a cervical rib can be palpated as a hard mass above the clavicle.

 Differential Diagnosis

When considering cervical rib, the differential diagnosis includes conditions that can cause similar symptoms, particularly those associated with thoracic outlet syndrome. These conditions include:

1. Scalene Syndrome: Compression of the brachial plexus or subclavian vessels by the anterior scalene muscle.

2. Pancoast Tumor: A tumor at the apex of the lung that can compress the brachial plexus or subclavian vessels, mimicking TOS.

3. Clavicular Fracture or Callus: Abnormal bone growth following a fracture that can compress neurovascular structures.

4. Congenital Band: Fibrous bands in the thoracic outlet that can cause similar compression effects.

5. Carpal Tunnel Syndrome: Compression of the median nerve at the wrist causing hand symptoms, which can sometimes be confused with neurological symptoms of TOS.

6. Brachial Plexopathy: Generalized conditions affecting the brachial plexus, such as radiation-induced brachial plexopathy or inflammatory brachial plexopathy.

 Diagnosis

- Physical Examination: Detailed neurovascular examination of the upper limb.

- Imaging:

  - X-ray: Often reveals the presence of a cervical rib.

  - MRI/CT Scan: Detailed imaging to assess the extent of the rib and its impact on surrounding structures.

  - Doppler Ultrasound: Used to evaluate vascular compression.

- Nerve Conduction Studies/EMG: To assess the extent of nerve involvement.

 Management

- Conservative Treatment: Physical therapy, pain management, and lifestyle modifications to avoid activities that exacerbate symptoms.

- Surgical Intervention: In cases where conservative management fails, surgical removal of the cervical rib may be considered to relieve neurovascular compression.

b] Von Recklinghausen's Disease of nerve [     Generalized Neurofibromatosis]

Etiology

Von Recklinghausen's disease, also known as Neurofibromatosis Type 1 (NF1), is a genetic disorder caused by mutations in the NF1 gene located on chromosome 17. This gene encodes neurofibromin, a protein that acts as a tumor suppressor. The mutation leads to uncontrolled cell growth, resulting in multiple benign tumors along nerves, as well as other abnormalities.

Clinical Findings

1. Café-au-lait Spots: Light brown skin patches that usually appear in early childhood.

   

2. Neurofibromas: Benign nerve sheath tumors that can occur anywhere on the body. They are typically soft, rubbery, and can be painful or cause functional impairment depending on their size and location.

3. Lisch Nodules: Hamartomas of the iris visible on slit-lamp examination, often appearing in childhood.

4. Freckling: Axillary or inguinal freckling, which is a diagnostic criterion for NF1.

5. Skeletal Abnormalities: Scoliosis, tibial dysplasia, and other bone deformities.

6. Optic Gliomas: Tumors of the optic pathway, which can cause vision problems.

7. Learning Disabilities: Approximately 50% of individuals with NF1 may have learning disabilities.

8. Increased Risk of Malignancies: Patients with NF1 have an increased risk of developing certain cancers, such as malignant peripheral nerve sheath tumors (MPNST).

 Differential Diagnosis

1. Neurofibromatosis Type 2 (NF2): Characterized by bilateral vestibular schwannomas and other intracranial and spinal tumors.

2. Legius Syndrome: Similar to NF1 with café-au-lait spots and freckling, but without neurofibromas or Lisch nodules.

3. Noonan Syndrome: Can present with café-au-lait spots but has distinctive facial features and heart defects.

4. McCune-Albright Syndrome: Characterized by café-au-lait spots, endocrine abnormalities, and polyostotic fibrous dysplasia.

5. Multiple Endocrine Neoplasia Type 1 (MEN1): Can present with multiple tumors but involves endocrine glands.

 Diagnosis

- Clinical Criteria: Diagnosis is often based on the presence of two or more of the following:

  - Six or more café-au-lait spots (greater than 5mm in prepubertal individuals, 15mm in postpubertal individuals).

  - Two or more neurofibromas or one plexiform neurofibroma.

  - Freckling in the axillary or inguinal regions.

  - Optic glioma.

  - Two or more Lisch nodules.

  - A distinctive osseous lesion such as sphenoid dysplasia or thinning of long bone cortex.

  - A first-degree relative with NF1.

- Genetic Testing: Can confirm the diagnosis by identifying mutations in the NF1 gene.

Management

- Regular Monitoring: Regular follow-up appointments to monitor for complications, including vision and neurological assessments.

- Symptomatic Treatment: Pain management, physical therapy, and interventions for learning disabilities.

- Surgical Intervention: Removal of neurofibromas that cause pain, functional impairment, or significant cosmetic concern. Surgery may also be necessary for optic gliomas or other complications.

- Pharmacological Treatment: Emerging treatments targeting the molecular pathways affected by NF1 mutations are being researched.

- Patient Education and Support: Providing information about the disease, genetic counseling, and support groups for patients and families.

c] Difference Between Cerebral Concussion And   Cerebral Compression

d] Leprosy - pathology, Clinical feature, and Treatment

👉 Pathology

Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by the bacterium *Mycobacterium leprae*. This organism primarily affects the skin, peripheral nerves, mucosa of the upper respiratory tract, and the eyes. The pathology involves:

- Infection and Spread: *M. leprae* is transmitted via droplets from the nose and mouth during close and frequent contact with untreated cases. It invades the skin and peripheral nerves, particularly Schwann cells.

- Immune Response: The body's immune response determines the form and severity of the disease. The spectrum of disease ranges from tuberculoid (paucibacillary) leprosy with strong cell-mediated immunity and few bacilli, to lepromatous (multibacillary) leprosy with weak cell-mediated immunity and numerous bacilli.

- Nerve Damage: Chronic inflammation and immune response lead to nerve damage, which is a hallmark of the disease. This can result in sensory loss and muscle weakness.

👉Clinical Features

Leprosy manifests in a wide range of clinical features depending on the form and severity of the disease:

1. Skin Lesions:

   - Hypopigmented or Erythematous Macules: Flat, pale areas of skin that may be numb.

   - Nodules and Plaques: Raised areas of skin that can be red or flesh-colored.

   - Thickened Dermis: Especially in lepromatous leprosy, the skin may become thickened.

2. Neurological Symptoms:

   - Peripheral Nerve Involvement: Numbness, tingling, and muscle weakness.

   - Nerve Thickening: Palpable thickening of peripheral nerves such as the ulnar, median, peroneal, and posterior tibial nerves.

   - Sensory Loss: Loss of sensation, particularly in the extremities, leading to injuries and secondary infections.

3. Musculoskeletal Deformities:

   - Claw Hand: Due to ulnar and median nerve damage.

   - Foot Drop: Due to peroneal nerve involvement.

   - Facial Deformities: Including loss of eyebrows and thickening of facial skin.

4. Ocular Involvement: Dry eyes, lagophthalmos (inability to close the eyelids completely), and potential blindness due to corneal damage.

5. Systemic Symptoms: In severe cases, there may be systemic involvement leading to general malaise, fever, and lymphadenopathy.

👉 Treatment

Leprosy is treated with a combination of antibiotics known as multidrug therapy (MDT) to prevent the development of drug resistance. The World Health Organization (WHO) recommends the following regimens:

1. Paucibacillary Leprosy (1-5 skin lesions):

   - Rifampicin: 600 mg once monthly.

   - Dapsone: 100 mg daily.

   - Duration: 6 months.

2. Multibacillary Leprosy (more than 5 skin lesions):

   - Rifampicin: 600 mg once monthly.

   - Clofazimine: 300 mg once monthly and 50 mg daily.

   - Dapsone: 100 mg daily.

   - Duration: 12 months.

3. Additional Measures:

   - Management of Reactions: Corticosteroids and other immunosuppressive drugs are used to manage lepra reactions (acute inflammatory complications).

   - Rehabilitation: Physical therapy, protective footwear, and surgical interventions to manage deformities and disabilities.

   - Education and Support: Patient education to prevent transmission, manage the disease, and reduce stigma. Support groups and social services can be helpful.

4. Follow-Up: Regular follow-up to monitor treatment response and manage complications.

e] Upper GIT- Bleeding - Causes

Causes of Upper Gastrointestinal (GIT) Bleeding

Upper gastrointestinal (GIT) bleeding refers to bleeding that originates from the upper part of the digestive tract, which includes the esophagus, stomach, and the first part of the small intestine (duodenum). Here are the primary causes:

👉 Esophageal Causes

1. Esophageal Varices: 

   - Dilated veins in the esophagus, often due to liver cirrhosis and portal hypertension.

2. Esophagitis:

   - Inflammation of the esophagus, commonly caused by gastroesophageal reflux disease (GERD).

3. Mallory-Weiss Tear:

   - A tear in the mucous membrane at the junction of the esophagus and stomach, usually due to severe vomiting or retching.

4. Esophageal Cancer:

   - Malignant growths that can ulcerate and bleed.

👉 Gastric Causes

1. Peptic Ulcer Disease:

   - Ulcers in the stomach (gastric ulcers) or duodenum (duodenal ulcers) caused by Helicobacter pylori infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).

2. Gastritis:

   - Inflammation of the stomach lining, which can be caused by alcohol, NSAIDs, or infections.

3. Gastric Cancer:

   - Malignant tumors in the stomach that can erode blood vessels and cause bleeding.

4. Gastric Varices:

   - Dilated veins in the stomach, similar to esophageal varices, often associated with portal hypertension.

👉Duodenal Causes

1. Duodenal Ulcer:

   - Similar to gastric ulcers, these are often caused by H. pylori infection or NSAIDs.

2. Vascular Lesions:

   - Includes arteriovenous malformations, Dieulafoy’s lesion (a large tortuous arteriole that can cause significant bleeding), and angiodysplasia.

👉 Other Causes

1. Aortoenteric Fistula:

   - A rare but life-threatening condition where an abnormal connection forms between the aorta and the gastrointestinal tract, usually secondary to abdominal aortic aneurysm or aortic graft surgery.

2. Hemobilia:

   - Bleeding into the biliary tract, often due to trauma, surgery, or tumors.

3. Pancreatic Causes:

   - Including pancreatic cancer or pancreatitis leading to splenic vein thrombosis and resultant gastric varices.

4. Erosive Diseases:

   - Conditions like erosive esophagitis, erosive gastritis, and erosive duodenitis, where the lining of the GI tract is eroded and bleeds.

5. Medications:

   - Long-term use of NSAIDs, aspirin, anticoagulants, and antiplatelet drugs can increase the risk of bleeding.

6. Infections:

   - Infections such as cytomegalovirus (CMV) or fungal infections in immunocompromised patients can lead to ulcerations and bleeding.

f] Intermittent Claudication - Causes and   Clinical Features

👦 Intermittent Claudication
👉 Causes
Intermittent claudication is a symptom characterized by pain and cramping in the lower extremities, typically triggered by exercise and relieved by rest. It is most commonly associated with peripheral arterial disease (PAD), which results from atherosclerosis. Here are the primary causes:

1. Peripheral Arterial Disease (PAD):

   - Atherosclerosis: The most common cause, where plaque builds up in the arterial walls, leading to narrowed and stiffened arteries, reducing blood flow to the limbs.

   - Arterial Stenosis or Occlusion: Narrowing or blockage of the arteries supplying the lower extremities.

2. Vasculitis:
   - Inflammatory conditions like Buerger’s disease (thromboangiitis obliterans) or Takayasu arteritis can lead to arterial narrowing and claudication.

3. Arterial Embolism:
   - Blockage of an artery by an embolus (a blood clot, fat, or other substance) that travels from another part of the body.

4. Diabetes Mellitus:
   - Chronic high blood sugar levels can damage blood vessels and contribute to atherosclerosis and PAD.

5. Smoking:
   - A major risk factor for atherosclerosis and PAD, significantly increasing the risk of claudication.

6. Hyperlipidemia:

   - High levels of cholesterol and triglycerides in the blood contribute to the development of atherosclerotic plaques.
7. Hypertension:

   - High blood pressure can damage the arterial walls, promoting atherosclerosis.
8. Obesity and Sedentary Lifestyle:

   - These factors increase the risk of developing atherosclerosis and PAD.

👉 Clinical Features

Intermittent claudication typically presents with the following clinical features:

1. Pain:

   - Cramping or aching pain in the muscles of the lower extremities, particularly the calves, thighs, or buttocks.

   - Pain is induced by exercise (walking, climbing stairs) and relieved by rest.

2. Location of Pain:
   - Calf pain is most common, but pain can also occur in the thighs, hips, or buttocks, depending on the location of arterial blockage.

3. Severity of Symptoms:
   - The distance a patient can walk before pain onset (claudication distance) decreases as the disease progresses.
   - Severe cases may lead to pain at rest, indicating critical limb ischemia

.
4. Other Signs and Symptoms:

   - Weak or Absent Pulses: Diminished or absent pulses in the feet or legs.

   - Cold or Pale Extremities: Affected limb may feel cooler or appear paler compared to the other limb.

   - Skin Changes: Shiny, thin skin, loss of hair on the legs, or thickened toenails.

   - Muscle Atrophy: Reduced muscle mass in the affected limb due to chronic reduced blood flow.

5. Ulcers or Gangrene:
   - In severe cases, non-healing wounds or gangrene can develop due to critical limb ischemia.

Diagnosis and Management

Diagnosis:

- Ankle-Brachial Index (ABI): A simple, non-invasive test comparing blood pressure in the ankle with blood pressure in the arm.

- Doppler Ultrasound: To assess blood flow and locate blockages.

- Angiography: Imaging of the blood vessels using contrast dye to pinpoint areas of occlusion.

Management:

- Lifestyle Modifications: Smoking cessation, regular exercise, and dietary changes to manage weight, blood pressure, and cholesterol levels.

- Medications: Antiplatelet agents (aspirin, clopidogrel), statins to manage cholesterol, and medications to improve blood flow (cilostazol).

- Interventional Procedures: Angioplasty, stenting, or bypass surgery to restore blood flow in severe cases.

- Wound Care and Prevention: Proper foot care to prevent ulcers and infections in patients with severe PAD.

By addressing the underlying causes and managing symptoms effectively, the prognosis for patients with intermittent claudication can be significantly improved.